What you may not know about antipsychotics: A guide for people taking antipsychotic drugs and their supporters

QR Code

What you may not know about antipsychotics: A guide for people taking antipsychotic drugs and their supporters

Bibliographic Details
Main Authors:	Dorozenko, Kate, Martin, R.
Format:	Report
Published:	National Mental Health Consumer and Carer Forum 2017
Online Access:	http://hdl.handle.net/20.500.11937/67793

Similar Items

The molecular basis of atypicality in antipsychotic drug action
by: Lockington, Hannah J.
Published: (2025)

Adherence to Antipsychotic Drug Measured by an Arabic Version of Morisky Scale
by: Alhalaiqa, F., et al.
Published: (2016)

Who is responsible for metabolic screening for mental health clients taking antipsychotic medications?
by: Ward, T., et al.
Published: (2017)

What You Need to Know about the PDPA
by: Zulhuda, Sonny
Published: (2012)

The role of oxidative stress in antipsychotics induced ovarian toxicity
by: Elmorsy, Ekramy, et al.
Published: (2017)

Improving metabolic monitoring rate for young people aged 35 and younger taking antipsychotic medications to treat a psychosis: A literature review
by: Chee, G., et al.
Published: (2017)

Bioenergetic disruption of human micro-vascular endothelial cells by antipsychotics
by: Elmorsy, Ekramy, et al.
Published: (2015)

Effect of antipsychotics on mitochondrial bioenergetics of rat ovarian theca cells
by: Elmorsy, Ekramy, et al.
Published: (2017)

Deciphering the neural mechanisms of oxytocin’s prosocial and antipsychotic-like effects
by: Abrahams, Abigail Bethany
Published: (2021)

Effect of the antipsychotic agent amisulpride on glucose lowering and insulin secretion
by: Roix, J., et al.
Published: (2012)

D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors
by: Bay-Richter, C., et al.
Published: (2013)

Knowing what you know about your faith an interactive application for measuring your faith in Islam
by: Gharamah, Abdulrahman, et al.
Published: (2018)

Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
by: Demjaha, Arsime, et al.
Published: (2017)

Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia
by: Bergman, Hanna, et al.
Published: (2017)

Survey of antipsychotic medication curriculum content in Australian university nursing programmes
by: Morrison, P., et al.
Published: (2017)

All you need to know about mooting
by: Zawawi, Majdah, et al.
Published: (2013)

The patterns of use and economic analysis of antipsychotic medications in treating hospitalized psychiatric patients
by: Sulistyarini, Arie
Published: (2012)

A role for rebinding in the prevalence of on-target side effects of clinically used antipsychotics
by: Sykes, David A
Published: (2020)

Everything you always wanted to know about drug cryptomarkets* (*but were afraid to ask)
by: Barratt, Monica, et al.
Published: (2016)

Adverse effects of antipsychotics on micro-vascular endothelial cells of the human blood–brain barrier
by: Elmorsy, Ekramy, et al.
Published: (2014)

Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
by: Sykes, David A., et al.
Published: (2017)

The effects of gestational use of antidepressants and antipsychotics on neonatal outcomes for women with severe mental illness
by: Frayne, J., et al.
Published: (2017)

Relationship of psychological symptoms, antipsychotics and social data with psychosocial function in schizophrenia patients in Malaysia
by: A.Talib, Norlelawati, et al.
Published: (2015)

Alcohol Use Disorders Identification Test (AUDIT) scores are elevated in antipsychotic-induced hyperprolactinaemia
by: Lawford, B., et al.
Published: (2012)

Medical ethics: What you should know?
by: Mohd Rizal Abdul Manaf,
Published: (2012)

"You can't ask questions about what you don't know". Determing the needs of patients with high grade gliomas and their carers
by: Halkett, Georgia, et al.
Published: (2007)

Relationship of brain derived neurotrophic factor DNA methylation with psychopathologic symptoms and antipsychotics in stable schizophrenia
by: Abd. Rahim, Nour El Huda, et al.
Published: (2016)

Things that you should know about post LASIK cataract
by: Md Mustafa, Md Muziman Syah
Published: (2018)

Things that you should know about post LASIK cataract
by: Md Mustafa, Md Muziman Syah
Published: (2019)

Knowing Me, Knowing You
by: Carr, A., et al.
Published: (2017)

Leaders debate the GST: What you need to know
by: Grattan, M., et al.
Published: (2015)

What women should know about OPAAW
by: Kamaruddin, Zaleha, et al.
Published: (2019)

Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents
by: Cheng, J., et al.
Published: (2015)

Hyperglycemia-induced involuntary movements : what you should know
by: Mohd Fazrul M,, et al.
Published: (2018)

Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial
by: Howard, Robert, et al.
Published: (2018)

Getting to know you
by: New Straits Times,
Published: (2013)

Antipsychotic prescribing to patients diagnosed with dementia without a diagnosis of psychosis in the context of national guidance and drug safety warnings: longitudinal study in UK general practice
by: Stocks, S. Jill, et al.
Published: (2017)

What Do You Know about Alternative Energy? Development and Use of a Diagnostic Instrument for Upper Secondary School Science
by: Cheong, I., et al.
Published: (2015)

The Gender Gap in Financial Security: What We Know and Don't Know about Australian Households
by: Austen, Siobhan, et al.
Published: (2014)

Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points
by: McMillan, Sara S., et al.
Published: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eis2gi8risgd21e7u4n436ra0f